
Tylenol, Theraflu, NyQuil, and DayQuil
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Juneau et al. v. The Procter & Gamble Co. and GSK Consumer Healthcare, Inc.
23-cv-5273, E.D. La.
(Sept. 2023)
DayQuil Severe, NyQuil Severe Cold & Flu, Theraflu Multi-Symptom Severe Cold/Severe Cold Cough, and other cold and flu medicines
Falsely marketing that medicines treat nasal congestion when the active ingredient (phenylephrine) is not an effective decongestant
Pending
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines are decongestants
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Misleadingly marketing drink mixes using the phrase “Natural fruit flavor” and images of raspberries when they contain artificial flavoring ingredients
Allegations: Misleadingly marketing products as if they treat symptoms of coughs and colds
Allegations: False natural claims
Allegations: False natural claims
TINA.org found the German automaker didn’t have the support to claim its Sprinter van was “built in the USA.”
These brand-relationship disclosures are far from world-class.
Instant replay shows six instances in which Super Bowl 52 advertisers have fumbled ad claims.
Ad Watchdog TINA.org Files FTC Complaint MADISON, CONN. January 23, 2018 – Despite a national advertising campaign showcasing patriotic imagery, highlighting its Boston headquarters, and heavily promoting its “Made in…
TINA.org files FTC complaint over Gillette’s false and deceptive Made in the USA claims.